Cost Effectiveness Analysis of Plasma Genotyping Versus Tumor Genotyping in Detection of Advanced Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor and T790M Mutation Under the Brazilian Private Healthcare System Perspective
Jornal Brasileiro de Economia da Saúde
doi 10.21115/jbes.v10.n3.p262-8
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Jornal Brasileiro de Economia da Saude